Zhejiang Shengda Bio-Pharm Co., Ltd.SSE: 603079

Report for Q3 2025

Oct 30, 2025 · Issued by Zhejiang Shengda Bio-Pharm Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Oct 30, 2025

On 6ix: 6ix.com/news/report-for-q3-2025-485

Report for Q3 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

Zhejiang Shengda Bio-Pharm Co., Ltd. on 6ix

Earlier from Zhejiang Shengda Bio-Pharm

Announcement on Convening the 2025 Q3 Performance BriefingOct 10, 2025
Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2025Sep 11, 2025
Announcement on Convening the 2025 Semi-annual Performance BriefingSep 5, 2025
Announcement on Resolutions of the 17th Meeting of the 4th Board of SupervisorsAug 26, 2025
Announcement on Obtaining Government SubsidiesAug 20, 2025

Later from Zhejiang Shengda Bio-Pharm

Announcement on Completion of Non-trading Transfer under the 2024 Employee Stock Ownership PlanOct 31, 2025
Announcement on Resolutions of the 21st Meeting of the 4th Board of DirectorsNov 28, 2025
Announcement on Progress in Idle Raised Funds Used for Cash ManagementDec 13, 2025
Announcement on Resolutions of the 4th Extraordinary General Meeting in 2025Dec 16, 2025
Announcement on Lifting of Trading Restrictions for Restricted Shares Issued to Specific ObjectsDec 19, 2025

All Zhejiang Shengda Bio-Pharm news releases

Follow Zhejiang Shengda Bio-Pharm into a list and get an email when it puts out news.

Follow Zhejiang Shengda Bio-Pharm